| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6065859 | Journal of Allergy and Clinical Immunology | 2014 | 9 Pages |
Abstract
The MastFx score distinguishes patients with ISM at high, intermediate, and low risk of new FFxs. The included characteristics sex, serum type I collagen C-telopeptide, hip bone mineral density, urticaria pigmentosa, and alcohol intake are easy to collect in clinical practice. The high occurrence of FFxs in patients with ISM underlines the importance of optimizing bone quality and early start of therapeutic prevention in patients at risk.
Keywords
SctxBTMFRAXROCISMBMDAUCindolent systemic mastocytosisfracture risk assessment toolSystemic mastocytosisAlcoholBone mineral densitySexUrticaria pigmentosabody mass indexBMIFragility fractureFragility fracturesBone turnover markersmethylhistaminearea under the curvehazard ratiobone turnover markerreceiver operating characteristic
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Eveline PhD, Suzanne PhD, Sjoukje BSc, Joris B. BSc, Jan G.R. MD, PhD, Joanna N.G. MD, PhD, Jasper J. MD, PhD,